ABCC1 and hepatocellular carcinoma: Further experiments reveal the regulatory mechanism of NR2F1‐AS1/miR‐363/ABCC1 pathway on HCC oxaliplatin resistance, suggesting the vital role of NR2F1‐AS1 in HCC research and providing the novel therapeutic target.